Ameren Corporation

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +35

BMO Capital Markets Lowers Ameren (NYSE:AEE) Price Target to $119.00

AI-generated analysis

πŸ“‰ BMO Capital Markets reduced Ameren's price target from $121.00 to $119.00 while keeping an 'outperform' rating.

πŸ“ˆ JPMorgan Chase increased its price target to $137.00 and maintained an 'overweight' rating in a July 16th report.

πŸ’° Ameren reported Q2 EPS of $1.28, beating the consensus estimate of $1.17 by $0.11.

πŸ“Š Revenue reached $2.18 billion for the quarter, representing a 3.8% increase year-over-year.

🏦 The company achieved a net margin of 17.17% and a return on equity of 10.94%.

πŸ‘€ SVP Theresa A. Shaw sold 325 shares for $35,451 under a pre-arranged Rule 10b5-1 trading plan.

πŸ“‰ Insider ownership decreased by 0.99% following the sale transaction filed with the SEC.

🏒 Institutional ownership stands at 79.09%, with several funds increasing stakes in Q2 and Q4.

🎯 Analyst consensus is a 'Moderate Buy' with an average price target of $121.50.

⚑ Ameren operates as an integrated energy company serving residential, commercial, and industrial customers in Missouri and Illinois.

Bullish Signals
  • Ameren beat earnings expectations with $1.28 EPS versus the $1.17 consensus estimate.
  • Revenue grew by 3.8% year-over-year to reach $2.18 billion for the quarter.
  • JPMorgan Chase raised its price target significantly to $137.00 and maintained an 'overweight' rating.
  • The company maintains healthy profitability with a net margin of 17.17% and ROE of 10.94%.
  • BMO Capital Markets continues to rate the stock as 'outperform' despite the slight target reduction.
Risk Factors
  • BMO Capital Markets lowered its price target from $121.00 to $119.00, indicating a slight bearish adjustment.
  • Quarterly revenue of $2.18 billion missed analyst estimates of $2.24 billion.
Full Analysis
BMO Capital Markets lowered its price target on Ameren Corporation (NYSE: AEE) from $121.00 to $119.00, maintaining an 'outperform' rating which implies roughly 5% upside from current levels. This adjustment contrasts with recent bullish moves by other major institutions; JPMorgan Chase raised its target to $137.00 in mid-July, while Barclays and Morgan Stanley also increased their targets recently. The consensus among analysts remains a 'Moderate Buy' with an average price target of $121.50 based on data from MarketBeat.com. Ameren reported strong financial results for the quarter ended April 30th, issuing earnings on May 5th that beat analyst expectations. The utility provider posted $1.28 in earnings per share compared to a consensus of $1.17, driven by revenue growth of 3.8% year-over-year to reach $2.18 billion. Key financial metrics included a net margin of 17.17% and a return on equity of 10.94%, demonstrating solid operational performance despite slightly lower-than-expected revenue. The article details significant insider activity and institutional ownership changes regarding Ameren. Senior Vice President Theresa A. Shaw sold 325 shares under a pre-arranged Rule 10b5-1 trading plan, reducing her stake by nearly 1%. Meanwhile, several small institutional investors like Osterweis Capital Management and Sound Income Strategies increased their holdings significantly during the second and fourth quarters, though these positions remain relatively small in absolute terms compared to the company's total market cap.